A REVIEW ON USE OF NANOPARTICLES IN THE TREATMENT OF DIABETES MELLITUS
Clicks: 1
ID: 309270
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #146 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. This essay provides a comprehensive overview of diabetes mellitus, exploring its types, etiology, pathophysiology, diagnosis, and treatment and management strategies. Additionally, it discusses the emerging field of nanoparticle-based therapies and their potential use in diabetes mellitus management. A thorough understanding of these aspects is essential for effectively managing diabetes and improving patient outcomes.
| Reference Key |
imported_1761930159_6904ebafe4a1e
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tichakunda Xavier Mharazanye |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2024 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.